Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NSCLC × sugemalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Small Cell Lung Carcinoma 1 Neoplasm, Residual 1 NSCLC 1 Lung Neoplasms 1

Interventions

Drug Therapy 4 Radiotherapy 3 osimertinib 2 aflutinib 2 Radiosurgery 2 Pemetrexed 2 Carboplatin 2 trilaciclib 1 toripalimab 1 tislelizumab 1 sugemalimab 1 spartalizumab 1 sintilimab 1 pembrolizumab 1 cemiplimab 1 Vinorelbine 1 Platinum 1 Paclitaxel 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07247227 2025-11-25

Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

Peking Union Medical College

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡